TLVAX | VEXMX | TLVAX / VEXMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 26 years | 37 years | - |
Gain YTD | 4.519 | 5.451 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 341M | 111B | 0% |
Annual Yield % from dividends | 0.42 | 1.09 | 38% |
Returns for 1 year | 5.63 | 23.65 | 24% |
Returns for 3 years | 9.07 | 26.07 | 35% |
Returns for 5 years | 31.50 | 58.65 | 54% |
Returns for 10 years | 28.25 | 136.68 | 21% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FZAJX | 21.12 | 0.10 | +0.48% |
Fidelity Advisor International Growth Z | |||
ASLAX | 14.74 | 0.06 | +0.41% |
AB Select US Long/Short A | |||
GSMVX | 17.54 | N/A | N/A |
Goldman Sachs Small/Mid Cap Value Instl | |||
CNZLX | 10.47 | -0.04 | -0.38% |
Commonwealth Australia/New Zealand | |||
FSCHX | 14.13 | -0.11 | -0.77% |
Fidelity Select Chemicals |